Roxanne Kelly

Roxanne Kelly is an experienced Senior Manager in Biomarkers Study Management at Biogen, where they oversee the operational aspects of bioanalytical and biomarker sample management for global clinical trials. Previously, Roxanne served as a Senior Research Laboratory Manager at Channing Laboratory, Harvard University, managing a large-scale biorepository and genetics research laboratory while collaborating with principal investigators on study designs and grant proposals. They have also held positions at AstraZeneca and Moderna, contributing significantly to drug discovery and biomarker operations. Roxanne holds a Bachelor of Science in Microbiology from the University of Manitoba and dual master's degrees in Finance and an MBA from Northeastern University.